PNS19 Design of study to assess impact of electronic chronic pain questions on patient-reported outcomes and healthcare utilization in a United States general practice setting
Recommended Citation
Shah V, Lamerato L, Abraham L, Cappelleri J, DeLor B, Ellsworth S, Hegeman-Dingle R, and Park PW. PNS19 Design of study to assess impact of electronic chronic pain questions on patient-reported outcomes and healthcare utilization in a United States general practice setting. Value in Health 2020; 23:S287.
Document Type
Conference Proceeding
Publication Date
5-2020
Publication Title
Value in Health
Abstract
Gaps exist in capturing real world data for chronic pain, making it difficult for physicians to assess and monitor patients, and for healthcare organizations to understand prevalence, utilization trends, and the impact of diagnosis and treatment decisions for chronic pain patients. The Electronic Chronic Pain Questions (eCPQ) is a 14-item questionnaire developed and psychometrically validated to help providers capture relevant chronic pain data from the electronic health record (EHR). A prospective, randomized pragmatic study is underway to determine if utilizing the eCPQ within a primary care practice setting results in improved patient-reported function and overall improvement. The eCPQ is being self-administered immediately prior to patient visits to those in the intervention group. Answers are then reviewed by their physician during the visit. Other questionnaires, including the Brief Pain Inventory-Short Form (BPI-sf), Patient Global Assessment (PGA) and the Patient Health Questionnaire for Depression and Anxiety (PHQ-2 and PHQ-9) are being administered following the appointment in order not to influence the standard of care (SOC). Patients in both the intervention and control groups will be evaluated at baseline, 6 and 12 months for their chronic pain condition as per SOC. The main outcome is the BPI-sf interference score change from baseline to 6 months comparing the control and intervention groups, with the PGA scores at 6 months a co-primary endpoint. After both their 6 and 12-month visits the intervention group will be invited to complete a survey to assess ease of use, utility, feasibility, and satisfaction with the eCPQ and their perception of its impact on their care. Providers will also complete a similar survey towards the end of the study. A subset in the intervention arm will also be randomly assigned to participate in a qualitative interview to further explore patients’ perception of the eCPQ. Providers will also be interviewed.
Volume
23
First Page
S287